Jean-Michel is Erasca’s Vice President of Chemistry and brings more than 25 years of experience in drug discovery and development to help fuel the company’s mission of erasing cancer. At Erasca, he is leading a talented group of medicinal, computational, development and analytical scientists dedicated to discovering and advancing new medicines to treat patients with cancer. Jean-Michel joined Erasca from Ignyta, where he led the chemistry department managing all of Ignyta’s drug substance GMP production as well as early stage internal drug discovery programs. During his time at Ignyta, Jean-Michel accumulated a strong knowledge in drug discovery, GMP production, IND and NDA filings. Before working at Ignyta, he held positions of increasing responsibilities at several companies, including Ardea Biosciences, Merck Research Laboratories and SIBIA neurosciences. Jean-Michel has co-authored more than 30 peer-reviewed publications and is an inventor on more than 50 U.S. patents. He earned his Ph.D. in Synthetic Organic Chemistry from the University Louis Pasteur, Strasbourg, France and was a postdoctoral fellow at Colorado State University.